Cystathionine Beta Synthase (CBS)

Cystathionine Beta Synthase (CBS)

Introduction

Cystathionine Beta Synthase (CBS) is a pyridoxal phosphate (PLP)-dependent enzyme that catalyzes the condensation of serine and homocysteine to form cystathionine, a critical intermediate in the transsulfuration pathway. This enzymatic reaction represents the rate-limiting step in the conversion of homocysteine to cysteine, which is essential for the synthesis of glutathione (GSH), the primary cellular antioxidant[@kraus1999] [1](https://pubmed.ncbi.nlm.nih.gov/10447260/). Beyond its canonical role in amino acid metabolism, CBS is a key producer of hydrogen sulfide (H₂S), a gasotransmitter with potent neuroprotective properties including anti-inflammatory, antioxidant, and anti-apoptotic effects[@marsden2010] [2](https://pubmed.ncbi.nlm.nih.gov/20436052/).

The dual functionality of CBS—producing both cysteine for GSH synthesis and H₂S for cell signaling—makes it a crucial enzyme in maintaining neuronal health. CBS dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease, as well as the inherited metabolic disorder homocystinuria[@yang2018] [3](https://pubmed.ncbi.nlm.nih.gov/29708026/).

Cystathionine Beta Synthase (CBS)

Introduction

Cystathionine Beta Synthase (CBS) is a pyridoxal phosphate (PLP)-dependent enzyme that catalyzes the condensation of serine and homocysteine to form cystathionine, a critical intermediate in the transsulfuration pathway. This enzymatic reaction represents the rate-limiting step in the conversion of homocysteine to cysteine, which is essential for the synthesis of glutathione (GSH), the primary cellular antioxidant[@kraus1999] [1](https://pubmed.ncbi.nlm.nih.gov/10447260/). Beyond its canonical role in amino acid metabolism, CBS is a key producer of hydrogen sulfide (H₂S), a gasotransmitter with potent neuroprotective properties including anti-inflammatory, antioxidant, and anti-apoptotic effects[@marsden2010] [2](https://pubmed.ncbi.nlm.nih.gov/20436052/).

The dual functionality of CBS—producing both cysteine for GSH synthesis and H₂S for cell signaling—makes it a crucial enzyme in maintaining neuronal health. CBS dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease, as well as the inherited metabolic disorder homocystinuria[@yang2018] [3](https://pubmed.ncbi.nlm.nih.gov/29708026/).

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Cystathionine Beta Synthase (CBS)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Cystathionine Beta Synthase</td></tr>
<tr><td><strong>Gene</strong></td><td>[CBS](/genes/cbs)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P35520](https://www.uniprot.org/uniprot/P35520)</td></tr>
<tr><td><strong>PDB IDs</strong></td><td>1JBD, 1M54, 3O47, 5NHH</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>55.5 kDa</td></tr>
<tr><td><strong>Cofactor</strong></td><td>Pyridoxal phosphate (PLP)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, Mitochondria</td></tr>
<tr><td><strong>Expression</strong></td><td>Ubiquitous, high in brain, liver, kidney</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Homocystinuria, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Structure and Molecular Mechanism

Domain Architecture

CBS possesses a sophisticated modular structure that enables its dual catalytic functions:

N-terminal Catalytic Domain (1-413 aa):

• Contains the pyridoxal phosphate (PLP) binding site
• Hosts the active site where the condensation reaction occurs
• The PLP cofactor forms a Schiff base with a conserved lysine residue (Lys-119)
• Catalyzes the β-replacement reaction: serine + homocysteine → cystathionine

• Contains a heme b cofactor that influences protein stability
• The heme iron is coordinated by Cys-272 and His-353
• Serves as a regulatory element affecting enzyme activity
• heme binding is unique to CBS among mammalian PLP-dependent enzymes

• Contains two tandem CBS domains (CBS1 and CBS2)
• Binds S-adenosylmethionine (SAM), a key metabolic signal
• SAM binding dramatically activates CBS (up to 10-fold)
• Forms a dimerization interface for tetramer formation

Three-Dimensional Structure

CBS forms a functional homodimer or tetramer in solution:

• Dimeric assembly: Each monomer contains N-terminal catalytic and C-terminal regulatory domains
• Tetramer formation: Dimers can further associate into tetramers, enhancing stability
• Allosteric regulation: SAM binding to C-terminal domains propagates conformational changes to the catalytic site
• Active site geometry: The PLP Schiff base is positioned for optimal catalysis with substrates

Enzyme Catalytic Mechanism

The CBS-catalyzed reaction proceeds through the following steps:

Post-Translational Modifications

CBS activity is modulated by several post-translational mechanisms:

• S-adenosylmethionine (SAM) binding: Primary allosteric activator
• S-adenosylhomocysteine (SAH) inhibition: Product inhibitor
• Heme binding: Stabilizes the protein structure
• Oxidative modifications: Reactive oxygen species can inhibit activity
• Phosphorylation: Several kinases may regulate CBS activity

Normal Physiological Functions

CBS serves as a critical metabolic hub connecting several essential biochemical pathways in the brain and other tissues.

Transsulfuration Pathway

CBS is the rate-limiting enzyme in the transsulfuration pathway, which converts homocysteine to cysteine:

This pathway is essential for:

• Maintaining redox homeostasis through GSH synthesis
• Regulating homocysteine levels (elevated homocysteine is neurotoxic)
• Providing cysteine for protein synthesis and taurine synthesis

Hydrogen Sulfide Production

Beyond its role in transsulfuration, CBS is a major producer of hydrogen sulfide (H₂S) in the brain:

H₂S biosynthesis pathways:

H₂S functions in the brain:

Antioxidant Defense:

• Activates Nrf2 transcription factor
• Increases expression of antioxidant enzymes (GPx, SOD, CAT)
• Scavenges reactive oxygen species (ROS)
• Protects against mitochondrial dysfunction [4](https://pubmed.ncbi.nlm.nih.gov/31100345/)

• Inhibits NF-κB activation
• Reduces pro-inflammatory cytokine production
• Modulates microglial activation
• Attenuates neuroinflammation [5](https://pubmed.ncbi.nlm.nih.gov/37286941/)

• Acts as a neurotransmitter/neuromodulator
• Modulates NMDA receptor activity
• Influences synaptic plasticity and memory formation
• Regulates cerebral blood flow

• Preserves mitochondrial membrane potential
• Enhances electron transport chain complex activity
• Protects against mitochondrial permeability transition
• Promotes mitochondrial biogenesis

Blood-Brain Barrier Regulation

CBS-derived H₂S plays a role in maintaining blood-brain barrier (BBB) integrity:

• Tight junction protein expression
• Endothelial cell survival
• BBB permeability regulation

Role in Neurodegenerative Diseases

Alzheimer's Disease

CBS dysfunction contributes to Alzheimer's disease pathogenesis through multiple mechanisms:

Oxidative Stress:

• Reduced GSH synthesis compromises antioxidant defenses [6](https://pubmed.ncbi.nlm.nih.gov/20061640/)
• Elevated homocysteine increases oxidative damage
• Impaired H₂S production reduces cellular protection

• CBS deficiency exacerbates amyloid pathology in mouse models
• H₂S sulfhydrates GSK3β, inhibiting Tau hyperphosphorylation [7](https://pubmed.ncbi.nlm.nih.gov/33431651/)
• Reduced H₂S promotes amyloid-β toxicity

• H₂S preserves synaptic protein function
• CBS deficiency impairs synaptic plasticity
• Memory consolidation is affected

• H₂S inhibits NF-κB pathway activation
• Reduced CBS activity increases inflammatory responses
• Microglial activation is modulated by H₂S

• H₂S donors reduce cognitive deficits in AD models
• Betaine activates CBS and reduces amyloid-induced paralysis
• CBS/H₂S axis is a promising therapeutic target [8](https://pubmed.ncbi.nlm.nih.gov/34370889/)

Parkinson's Disease

CBS plays a protective role in dopaminergic neuron survival:

MPTP Toxicity:

• Impaired CBS/H₂S signaling contributes to MPTP-induced neurodegeneration [9](https://pubmed.ncbi.nlm.nih.gov/28774789/)
• H₂S protects against MPTP-induced complex I inhibition
• Dopaminergic neurons are particularly vulnerable to CBS dysfunction

• CBS-derived H₂S preserves mitochondrial complex IV activity [10](https://pubmed.ncbi.nlm.nih.gov/31176652/)
• Protects against mitochondrial ROS generation
• Maintains ATP production in dopaminergic neurons

• H₂S scavenges ROS in substantia nigra
• Protects dopaminergic neurons from oxidative damage
• Supports GSH synthesis for antioxidant defense

• H₂S may reduce α-synuclein aggregation
• Protein sulfhydration prevents misfolding
• Autophagy modulation by H₂S

Huntington's Disease

• Elevated homocysteine in HD patients
• CBS dysfunction contributes to transcriptional dysregulation
• H₂S neuroprotective effects in HD models

Stroke and Vascular Dementia

CBS/H₂S axis dysfunction contributes to ischemic brain injury:

• H₂S pre-conditioning provides neuroprotection [11](https://pubmed.ncbi.nlm.nih.gov/35473904/)
• CBS activity correlates with stroke outcome
• Blood-brain barrier protection by H₂S

Homocystinuria

CBS deficiency causes classic homocystinuria:

Metabolic Consequences:

• Elevated homocysteine and methionine in blood and urine
• Reduced cystathionine and cysteine levels
• Impaired GSH synthesis

• Intellectual disability if untreated
• Seizures
• Developmental delay

• Thromboembolic events
• Ectopia lentis
• Marfanoid habitus

• Vitamin B6 supplementation (some responsive mutations)
• Betaine supplementation
• Methionine-restricted diet
• Folate and vitamin B12 supplementation

Therapeutic Strategies

Targeting the CBS/H₂S axis offers promising therapeutic approaches for neurodegenerative diseases.

H₂S-Releasing Compounds

Fast H₂S Donors:

• NaHS (Sodium hydrosulfide): Rapid H₂S release, used in experimental studies
• Na₂S (Sodium sulfide): Another fast-acting donor
• Short-lived effects, useful for acute studies

• GYY4137: Slow, sustained H₂S release
• AP39: Mitochondria-targeted H₂S donor
• JK-1: Fluorescent H₂S donor

• Garlic-derived compounds: Allicin, diallyl sulfide
• Sulforaphane: Activates CBS expression via Nrf2

CBS Activators and Modulators

Direct CBS Activators:

• S-adenosylmethionine (SAM): Endogenous activator
• Betaine (trimethylglycine): Enhances CBS activity
• Vitamin B6 (pyridoxine): Essential cofactor

• Nrf2 activators: Increase CBS expression
• HDAC inhibitors: Upregulate CBS transcription
• Antioxidants: Reduce oxidative inhibition

Vitamin Supplementation Therapy

B Vitamin Complex:

• Vitamin B6 (pyridoxine): PLP cofactor precursor
• Vitamin B12 (cobalamin): Reduces homocysteine
• Folate: Converts homocysteine to methionine
• Combined B vitamin therapy reduces homocysteine

• B6-responsive vs. B6-non-responsive mutations
• Monitoring of homocysteine levels
• Personalized supplementation

Gene Therapy Approaches

• AAV-mediated CBS delivery: Viral vector gene therapy
• CRISPR-based editing: Correct pathogenic CBS mutations
• CBS expression modulation: Target regulatory elements

Symptomatic and Disease-Modifying Strategies

Neurotrophic Factors:

• BDNF delivery to support neurons
• Neurotrophin-mediated protection

• NF-κB inhibitors
• Microglial modulators

• CoQ10 and analogues
• Mitochondrial peptides

Protein-Protein Interactions

CBS interacts with several proteins to carry out its cellular functions:

Metabolic Enzymes

• Cystathionine γ-lyase (CGL/CSE): Downstream enzyme in transsulfuration
• Methionine adenosyltransferase (MAT): Produces SAM
• S-adenosylhomocysteine hydrolase (SAHH): Regulates SAH levels
• Glutathione synthetase: Uses cysteine for GSH production
• γ-glutamylcysteine synthetase: Rate-limiting GSH synthesis step

Signaling Proteins

• Nrf2: Transcription factor activated by H₂S
• NF-κB: Suppressed by H₂S signaling
• AMPK: Energy sensor modulated by H₂S
• GSK3β: Sulfhydration target in AD

Regulatory Proteins

• S-adenosylmethionine synthetase isoforms: Produce SAM
• Cystathionine β-synthase isoforms: Alternative splicing variants
• Heme oxygenase-1: Stress-responsive enzyme

Disease-Related Proteins

• APP: Alzheimer's disease amyloid precursor
• α-Synuclein: Parkinson's disease protein
• Tau: AD neurofibrillary tangles
• Parkin: PD-linked E3 ubiquitin ligase

Animal Models

Genetic Models

Cbs Knockout Mice:

• Embryonic lethality in complete knockouts
• Severe homocystinuria phenotype
• Oxidative stress and mitochondrial dysfunction

• Partial CBS deficiency
• Elevated homocysteine
• Cognitive deficits in some models

• Protection against oxidative stress
• Enhanced H₂S production
• Improved cognitive function

Induced Models

Homocysteine-induced neurodegeneration:

• Elevated homocysteine injection
• Mimics homocystinuria features
• Cognitive impairment

• CBS deficiency in substantia nigra
• H₂S levels reduced
• Dopaminergic neuron loss

Phenotypic Comparisons

| Model | Species | Key Phenotypes | Relevance |
|-------|---------|----------------|-----------|
| Cbs-/- | Mouse | Embryonic lethality | Essential enzyme |
| Cbs+/- | Mouse | Elevated Hcy, cognitive deficits | Heterozygote model |
| MPTP | Mouse | PD-like neurodegeneration | PD model |
| Homocysteine injection | Rat | Oxidative stress, neuronal loss | Homocystinuria model |

Brain Atlas Resources

• [Allen Human Brain Atlas - CBS Expression](https://human.brain-map.org/microarray/search/show?search_term=CBS)
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/)
• [Human Protein Atlas - CBS Brain Expression](https://www.proteinatlas.org/learn/normal-tissues)

Research Directions

Current Questions

Emerging Techniques

• Single-cell proteomics: Profile CBS in specific neuronal populations
• H₂S biosensors: Real-time visualization of H₂S in living cells
• iPSC models: Patient-derived neurons for disease modeling
• CRISPR screening: Identify genetic modifiers of CBS function

Clinical Trials

• H₂S donors in AD/PD clinical trials (various phases)
• Betaine supplementation trials
• Vitamin B therapy trials in neurodegenerative diseases

See Also

• [CBS Gene](/genes/cbs)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Neuroprotection](/mechanisms/neuroprotection)

External Links

• [UniProt: P35520](https://www.uniprot.org/uniprot/P35520)
• [AlphaFold: CBS](https://alphafold.ebi.ac.uk/entry/P35520)
• [OMIM: 236200](https://www.omim.org/entry/236200)

References